DNTH – dianthus therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Dianthus Therapeutics (DNTH) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $135.00 price target on the stock.
Wedbush Keeps Outperform on Dianthus Therapeutics, Inc. (DNTH), Highlights Potential of Claseprubart in CIDP [Yahoo! Finance]
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit [Yahoo! Finance]
Dianthus Therapeutics (DNTH) had its "outperform" rating reaffirmed by William Blair.
Dianthus Therapeutics Hits Early “Go” in CAPTIVATE Phase 3 CIDP Trial, Drops 600 mg Arm [Yahoo! Finance]
Form 144 Dianthus Therapeutics, Filed by: Soteropoulos Paula
Form 4 Dianthus Therapeutics, For: Mar 16 Filed by: Garcia Marino
Form 4 Dianthus Therapeutics, For: Mar 12 Filed by: CARR EDWARD
Form 4 Dianthus Therapeutics, For: Mar 12 Filed by: Randhawa Simrat
Form 4 Dianthus Therapeutics, For: Mar 12 Filed by: Garcia Marino
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.